Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Date:7/14/2009

---- ---- ASSETS CURRENT ASSETS: Cash and cash equivalents $10,018,000 $15,130,000 Trade and other receivables 1,770,000 605,000 Government contract receivables 1,944,000 - Inventories, net 4,707,000 2,900,000 Debt issuance costs, current portion 229,000 - Prepaid expenses and other current assets, net 1,466,000 1,208,000 --------- --------- Total current assets 20,134,000 19,843,000 PROPERTY: Leasehold improvements 675,000 669,000 Laboratory equipment 4,180,000 4,140,000 Furniture, fixtures and computer equipment 902,000 919,000 ------- ------- 5,757,000 5,728,000 Less accumulated depreciation and amortization (4,076,000) (3,670,000) ---------- ---------- Property, net 1,681,000 2,058,000 Debt issuance costs, less current portion 142,000 - Other assets 1,170,000 1,156,000 --------- --------- TOTAL ASSETS $23,127,000 $23,057,000 =========== ===========

    PEREGRINE PHARMACEUTICALS, INC.

    CONSOLIDATED BALANCE SHEETS
    AS OF APRIL 30, 2009 AND 2008 (continued)

                                                        2009          2008
                                                
'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... In observance of World Malaria Day, ... Nets Pledge, a two-year pledge by the United Nations ... with one million bednets by 2016. This ambitious $10 ... partners to protect children, refugees, and families displaced by ... has been a large surge in refugee families displaced ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 The Hon. ... Worker Safety issues the following statement following the deadly ... hit Kathmandu, Nepal, resulting in the deaths of more ... earthquake were felt across Nepal, Bangladesh, India and other ... my heartfelt condolences to the people of Nepal and ...
(Date:4/25/2015)... New Jersey (PRWEB) April 25, 2015 ... people aged twelve and above needed treatment for an ... according to the Substance Abuse and Mental Health Services ... September 2011). Beyond these alarming numbers are harrowing stories ... by substance abuse . David H. Kerr ...
(Date:4/25/2015)... April 25, 2015 The federal ... mesh lawsuits filed against C.R. Bard, Inc. continues ... Southern District of West Virginia. According to a ... was convened that day, after certain defendants submitted ... Complaint. The Order directed that any Preliminary Motions ...
(Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog post that ... for flatbed trucks. , Flatbed trucks are ... They are mainly used for commercial purposes and thus ... explains that by comparing multiple offers, drivers can find ... vehicles. , It is now possible to compare free ...
Breaking Medicine News(10 mins):Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2
... Schizophrenia may blur the boundary between internal and external ... in self-reflection, and thus causing an exaggerated focus on ... has found. , The traditional view of schizophrenia ... characterize the disease are caused by disconnections among the ...
... aids can offer hope of better hearing for people ... conducted by the non-profit educational organization Better Hearing Institute ... the United States and Canada found that six out ... when using hearing aids and two of ten reported ...
... to Customers , LANDOVER, Md., Jan. 21 Recently, ... containing peanut butter and peanut paste from their shelves. ... salmonella to a plant owned by Peanut Corporation of ... our shelves including:, , ...
... influence medical care and research that demonstrates how science ... the list of cardiovascular disease and stroke advances from ... Heart Association.The American Heart Association has been compiling an ... heart disease and stroke research since 1996."It,s always difficult ...
... controls winter in Northern Hemisphere , , WEDNESDAY, Jan. 21 (HealthDay ... open earlier in the spring, and birds are migrating sooner, ... worldwide temperatures been rising for the last 50 years, but ... days earlier. , That,s the conclusion of a new ...
... A new study appearing in The Prostate has ... strain known as MV-CEA, may prove to be an effective ... that this type of treatment, called virotherapy, can effectively infect, ... cancer is a leading cause death among males in the ...
Cached Medicine News:Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 3Health News:Hearing Aids Offer Hope for Those Who Suffer from Persistent 'Ringing in the Ears,' Better Hearing Institute Survey Finds 2Health News:Hearing Aids Offer Hope for Those Who Suffer from Persistent 'Ringing in the Ears,' Better Hearing Institute Survey Finds 3Health News:Hearing Aids Offer Hope for Those Who Suffer from Persistent 'Ringing in the Ears,' Better Hearing Institute Survey Finds 4Health News:Giant Food Responds to Recall of Peanut Based Products 2Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 2Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 3Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 4Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 5Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 6Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 7Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 8Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 9Health News:American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities 10Health News:Seasons Arriving 2 Days Earlier, Study Says 2Health News:Measles virus may be effective prostate cancer treatment 2
(Date:4/25/2015)... April 2015 Hospira, Inc. ... Entwicklung von Biosimilar-Behandlungen, sprach heute auf der jährlichen ... (EGA) in London über ... Verfügbarkeit von Biosimilars für Patienten. Das ... Papers mit dem Titel „Why extrapolation is ...
(Date:4/25/2015)... -- With the introduction of Elekta,s new Leksell Gamma Knife® ... available for more patients with a wider variety of ... system for the brain, integrates advanced motion management, dose ... Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma Knife Icon ... Barcelona . "This is ...
(Date:4/24/2015)... , und BARCELONA , ... Nr. 4410) iCAD, Inc. (Nasdaq: ICAD ... Bildanalyse, Lösungen für Behandlungsabläufe und Strahlentherapie für ... heute die sofortige Verfügbarkeit des ersten Xoft ... (eBx ® ) System ® in ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 4Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 5Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 6
... NASHVILLE, Tenn. , April 26 Cumberland Pharmaceuticals Inc. ... preference study evaluating Kristalose® ( lactulose ) for Oral Solution, a prescription ... Digestive Disease Week® meeting in New Orleans .   , ... A poster presentation of the study, ...
... DIEGO , April 26 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... of Neurocrine Biosciences, will be presenting at the Deutsche Bank 35th Annual Health ... , , ... 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time . ...
Cached Medicine Technology:Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting 2Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting 3Neurocrine Biosciences to Present at the Deutsche Bank 35th Annual Health Care Conference 2
... The patented ratchet design provides fingertip ... ,The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ...
... A broad selection of procedurally specific ... and allow easy access to all ... variety of approaches.,Loop Handled Graspers feature ... holds tissue firmly without tearing or ...
... of procedurally specific tip configurations provide ... access to all areas of the ... Handled Graspers feature an "infinite position ... without tearing or slipping even ...
...
Medicine Products: